Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease

Sommer, Annika, Marxreiter, Franz, Krach, Florian, Fadler, Tanja, Grosch, Janina, Maroni, Michele, Graef, Daniela, Eberhardt, Esther +8 more·2018·Cell Stem Cell

DOI 10.1016/j.stem.2018.06.015

Cited by (331)

Items 101–200 of 331

Early-to-mid stage idiopathic Parkinson’s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females
Christophe Capelle, Séverine Ciré, Fanny Hedin, Maxime Hansen, Lukas Pavelka, Kamil Grzyb, Dimitrios Kyriakis, Oliver E. Hunewald, Maria Konstantinou, Dominique Revets et al. · 2023 · Nature Communications
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
Razvan-Marius Brazdis, Julian E. Alecu, Daniel Marsch, Annika Dahms, Katrin Simmnacher, Sandra Lörentz, Anna Brendler, Yanni Schneider, Franz Marxreiter, Laurent Roybon et al. · 2020 · Human Molecular Genetics
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates
Cosma-Grigorov, Alexandra, Meixner, Holger, Mrochen, Anne, Wirtz, Stefan, Winkler, Jürgen, Marxreiter, Franz · 2020 · Frontiers in Neurology
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Maamoon Saleh, Milica Marković, Katherine E. Olson, Howard Eliot Gendelman, Rodney Lee Mosley · 2022 · Journal of Parkinson s Disease
Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases
Michael Poppell, Grace Hammel, Yi Ren · 2023 · International Journal of Molecular Sciences
Human Adipose Tissue-Derived Mesenchymal Stem Cells in Parkinson’s Disease: Inhibition of T Helper 17 Cell Differentiation and Regulation of Immune Balance Towards a Regulatory T Cell Phenotype
Yong Hong Bi, Xiaobin Lin, Huazheng Liang, Dehao Yang, Xiaowei Zhang, Jianming Ke, Jingjing Xiao, Zhilin Chen, Weian Chen, Xu Zhang et al. · 2020 · Clinical Interventions in Aging
T cells, α-synuclein and Parkinson disease
Francesca Garretti, Connor Monahan, Alessandro Sette, Dritan Agalliu, David Sulzer · 2022 · Handbook of clinical neurology
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review
M. S. Khan, Somayyeh Nasiripour, Jean C. Bopassa · 2025 · International Journal of Molecular Sciences
Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
Ruichen Su, Tian Gang Zhou · 2021 · Frontiers in Aging Neuroscience
Fecal microbiota transplantation enhances cell therapy in a rat model of hypoganglionosis by SCFA‐induced MEK1/2 signaling pathway
Donghao Tian, Wenyao Xu, Weikang Pan, Baijun Zheng, Weili Yang, Wanying Jia, Yong Liu, Malgorzata Anna Garstka, Ya Gao, Hui Yu · 2022 · The EMBO Journal
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction
Andrea Mancini, Veronica Ghiglieri, Lucilla Parnetti, Paolo Calabresi, Massimiliano Di Filippo · 2021 · Frontiers in Immunology
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
Mohammad Badr, Rhonda L. McFleder, Jingjing Wu, Susanne Knörr, James B. Koprich, Thomas Hünig, Jonathan M. Brotchie, Jens Volkmann, Manfred Bernhard Lutz, Chi Wang Ip · 2022 · Journal of Neuroinflammation
Therapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation
Avtar Singh Gautam, Rakesh Kumar Singh · 2023 · Drug Discovery Today
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, Thérèse Di Paolo · 2023 · Brain Research Bulletin
α‐Synuclein in Parkinson's Disease: From Bench to Bedside
Gabriele Bellini, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, Carolina Pellegrini · 2024 · Medicinal Research Reviews
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, Eng-King Tan · 2025 · Neurologic Clinics
Chronic Infiltration of T Lymphocytes into the Brain in a Non-human Primate Model of Parkinson’s Disease
Jincheol Seo, Junghyung Park, Keonwoo Kim, Jinyoung Won, Hyeon-Gu Yeo, Yeung Bae Jin, Bon‐Sang Koo, Kyung Seob Lim, Kang-Jin Jeong, Philyong Kang et al. · 2020 · Neuroscience
Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, Vidar · 2021 · Frontiers in Neuroscience
Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease
Benjamin D. Hobson, David L. Sulzer · 2022 · Journal of Parkinson s Disease
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret Koroni Huber, Günter U. Höglinger, Florian Wegner · 2021 · Brain Sciences
7 tricks for 7 T CEST: Improving the reproducibility of multipool evaluation provides insights into the effects of age and the early stages of Parkinson's disease
Angelika Mennecke, Katrin M. Khakzar, Alexander German, Kai Herz, Moritz Simon Fabian, Andrzej Liebert, Ingmar Blümcke, Burkhard Sebastian Kasper, Armin Michael Nagel, Frederik Bernd Laun et al. · 2022 · NMR in Biomedicine
Th17 cells: a promising therapeutic target for Parkinson’s disease?
Iryna Prots, Beate Winner · 2019 · Expert Opinion on Therapeutic Targets
Inflammation in Experimental Models of α ‐Synucleinopathies
Ashley S. Harms, Jeffrey H. Kordower, Alessandro Sette, Cecilia S. Lindestam Arlehamn, David L. Sulzer, Robert H. Mach · 2020 · Movement Disorders
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Johan Wallin, Per Svenningsson · 2021 · International Journal of Molecular Sciences
Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
Lukas Seebauer, Yanni Schneider, Alice Drobny, Sonja Plötz, Tomáš Koudelka, Andreas Tholey, Iryna Prots, Beate Winner, Friederike Zunke, Jürgen Winkler et al. · 2022 · International Journal of Molecular Sciences
Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
Yajing Chen, Tingting Wu, Heng Li, Xuan Li, Qing Li, Xiaoying Zhu, Mei Yu, Sheng‐Han Kuo, Fang Huang, Yun‐Cheng Wu · 2019 · Frontiers in Aging Neuroscience
Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
Katrin Simmnacher, Jonas Lanfer, Tania Rizo, Johanna Kaindl, Beate Winner · 2020 · Frontiers in Cellular Neuroscience
In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration
Marialena Chrysanthou, Ignacio Miro Estruch, Ivonne M.C.M. Rietjens, Harry J. Wichers, Tamara Hoppenbrouwers · 2022 · Nutrients
Curcumin and its Potential for Systemic Targeting of Inflamm-Aging and Metabolic Reprogramming in Cancer
Renata Novak Kujundžić, Višnja Stepanić, Lidija Milković, Ana Čipak Gašparović, Marko Tomljanović, Koraljka Gall‐Tros̆elj · 2019 · International Journal of Molecular Sciences
Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain
Benjamin D. Hobson, Adrien T. Stanley, Mark B. De Los Santos, Bruce Culbertson, Eugene V. Mosharov, Peter A. Sims, David L. Sulzer · 2023 · Brain Behavior and Immunity
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Frontiers in Synaptic Neuroscience
Intracellular Alpha-Synuclein and Immune Cell Function
Veselin Grozdanov, Karin M. Danzer · 2020 · Frontiers in Cell and Developmental Biology
T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
Sonia George, Trevor Tyson, Nolwen L. Rey, Rachael T. C. Sheridan, Wouter Peelaerts, Katelyn Becker, Emily Schulz, Lindsay K. Meyerdirk, Amanda Rae Burmeister, Christian Ulrich von Linstow et al. · 2021 · Journal of Parkinson s Disease
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease
Lisa Rauschenberger, Jennifer K. Behnke, Alexander Grotemeyer, Susanne Knörr, Jens Volkmann, Chi Wang Ip · 2022 · Neurobiology of Disease
Unconventional T cells in brain homeostasis, injury and neurodegeneration
Mengfei Lv, Zhaolong Zhang, Yu Cui · 2023 · Frontiers in Immunology
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Jolene S.Y. Tan, Yinxia Chao, Olaf Rötzschke, Eng‐King Tan · 2020 · International Journal of Molecular Sciences
Novel Insights into Parkin–Mediated Mitochondrial Dysfunction and “Mito-Inflammation” in α-Synuclein Toxicity. The Role of the cGAS–STING Signalling Pathway
Magdalena Gąssowska-Dobrowolska, Gabriela Olech-Kochańczyk, Carsten Culmsee, Agata Adamczyk · 2024 · Journal of Inflammation Research
Effects of psychological stress on inflammatory bowel disease via affecting the microbiota–gut–brain axis
Yuhan Chen, Xiaofen Chen, Suqin Lin, Shengjun Huang, Lijuan Li, Mingzhi Hong, Jun Li, Lili Ma, Juan Ma · 2025 · Chinese Medical Journal
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, Narendran Annadurai, Marián Hajdúch, Juan Bautista De Sanctis · 2023 · Current Neuropharmacology
CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets
Yan Gao, Yaoping Lu, Xiaojing Liang, Mengwei Zhao, Xinyue Yu, Haiying Fu, Wei Yang · 2024 · Cells
Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
Drobny, Alice, Ngo, Phuong A., Neurath, Markus F., Zunke, Friederike, López-Posadas, Rocío · 2021 · Frontiers in Medicine
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, Ze Zhang, Lucas A. Salas · 2024 · npj Parkinson s Disease
Impaired migratory phenotype of CD4+ T cells in Parkinson’s disease
Dejan Mamula, Shervin Khosousi, Yachao He, Vesna Lazarevic, Per Svenningsson · 2022 · npj Parkinson s Disease
Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease
HariOm Singh, Amita Singh, Abdul Arif Khan, Vivek Kumar Gupta · 2021 · Microbial Pathogenesis
Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases
Citlalli Netzahualcoyotzi, Juan Jair Santillán‐Cigales, Laura Virginia Adalid-Peralta, Iván Velasco · 2024 · Journal of Neurochemistry
Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual-Center Study Using Adherent Vitrification
Johanna Kaindl, Ina Meiser, Julia Majer, Annika Sommer, Florian Krach, Alisa Katsen‐Globa, Jürgen Winkler, Heiko Zimmermann, Julia Christiane Neubauer, Beate Winner · 2018 · Stem Cells Translational Medicine
Mitochondrial antigen presentation: a mechanism linking Parkinson’s disease to autoimmunity
Ahmed M. Fahmy, Jonathan Boulais, Michel Desjardins, Diana Matheoud · 2019 · Current Opinion in Immunology
Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson’s disease
Elizaveta M. Gerasimova, Amke C. Beenen, Daniel V. Kachkin, Martin Regensburger, Sebastian Zundler, David B. Blumenthal, Gloria Lutzny‐Geier, Beate Winner, Iryna Prots · 2025 · npj Parkinson s Disease
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Xiaowei Sun, Rou Gu, Jie Bai · 2024 · Cellular and Molecular Life Sciences
Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma Alicia Martínez-Dávila, Cecilia Bañuelos, María Eugenia Gutiérrez-Castillo, Víctor Manuel Blanco-Álvarez, María del Carmen Cárdenas‐Aguayo, José Luna‐Muñoz, Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas · 2021 · International Journal of Molecular Sciences
Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
Mark van den Hurk, Shong Lau, Maria Carolina Marchetto, Jérôme Mertens, Shani Stern, Olga Corti, Alexis Brice, Beate Winner, Jürgen Winkler, Fred H. Gage et al. · 2022 · npj Parkinson s Disease
Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
Zijian Zheng, Shushan Zhang, Hanwen Zhang, Zhongzheng Gao, Xiangrong Wang, Xinjie Liu, Xue Cheng, Longping Yao, Guohui Lu · 2022 · Oxidative Medicine and Cellular Longevity
High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
Antonio Heras‐Garvin, Violetta Refolo, Markus Reindl, Gregor Karl Wenning, Nadia Stefanova · 2020 · Journal of Neuroinflammation
Th17 Cells in Parkinson’s Disease: The Bane of the Midbrain
Ashley C. Bolte, John R. Lukens · 2018 · Cell stem cell
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
Katiane Roversi, Natália Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot · 2021 · Frontiers in Immunology
The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
Boyuan Huang, Yan Zhenxin, Sisi Chen, Zhenhua Tan, Zhitao Zong, Hongbo Zhang, Xiaoxing Xiong · 2022 · Oxidative Medicine and Cellular Longevity
Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome
Shervin Khosousi, Abdul Hye, Latha Velayudhan, Björn Bloth, Panagiota Tsitsi, Ioanna Markaki, Per Svenningsson · 2023 · Parkinsonism & Related Disorders
Fecal microbiota transplantation regulates the microbiota-gut-spinal cord axis to promote recovery after spinal cord injury
Deshuang Xi, Pan Liu, Yanbing Feng, Yilin Teng, Yu Liang, Junhong Zhou, Hao Deng, Gaofeng Zeng, Shaohui Zong · 2023 · International Immunopharmacology
The role of T-lymphocytes in central nervous system diseases
Jianing Shen, Ning Bian, Lu Zhao, Jingkuan Wei · 2024 · Brain Research Bulletin
The role of IL-23/IL-17 axis in ischemic stroke from the perspective of gut-brain axis
Yang Jiang, Yajie Dai, Zhenquan Liu, Yan Liao, Shuyong Sun, Xianghe Kong, Jingjing Hu, Yibo Tang · 2023 · Neuropharmacology
Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
Pascale Baden, Cong Yu, Michela Deleidi · 2019 · Neurobiology of Disease
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Pons-Espinal, Meritxell, Blasco-Agell, Lucas, Consiglio, Antonella · 2021 · Cellular and Molecular Life Sciences
Emerging roles of leptin in Parkinson’s disease: Chronic inflammation, neuroprotection and more?
Regensburger, Martin, Rasul Chaudhry, Shafqat, Yasin, Hammad, Zhao, Yining, Stadlbauer, Andreas, Buchfelder, Michael, Kinfe, Thomas · 2023 · Brain, Behavior, and Immunity
Unaltered T cell responses to common antigens in individuals with Parkinson's disease
Gregory P. Williams, Kaylin Muskat, April Frazier, Yaqian Xu, José Mateus, Alba Grifoni, Ricardo da Silva Antunes, Daniela Weiskopf, Amy W. Amara, David G. Standaert et al. · 2022 · Journal of the Neurological Sciences
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Yi Zhuo, Xuan Li, Zhengwen He, Ming Lu · 2023 · Stem Cell Research & Therapy
Neuroimmune interactions and their roles in neurodegenerative diseases
Bai-Rong Chen, Ting Wu, Ting-Hui Chen, Yun Wang · 2023 · Fundamental Research
Meningeal lymphatic vessel crosstalk with central nervous system immune cells in aging and neurodegenerative diseases
Minghuang Gao, Xinyue Wang, Shijie Su, Weicheng Feng, Yaona Lai, Kongli Huang, Dandan Cao, Qi Wang · 2024 · Neural Regeneration Research
An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases
Yudai Xu, Zijian Wang, Shumin Li, Jun Su, Lijuan Gao, Junwen Ou, Zhanyi Lin, Oscar Junhong Luo, Chanchan Xiao, Guobing Chen · 2024 · Science China Life Sciences
Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools
Hailey B. Wheeler, Assael A. Madrigal, Isaac Alexander Chaim · 2024 · Proceedings of the National Academy of Sciences
From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
Yee Jie Yeap, Teddy J. W. Tng, Mok Jung Lee, Micaela Goh, Kah‐Leong Lim · 2023 · International Journal of Molecular Sciences
Myeloid and lymphoid expression of C9orf72 regulates IL-17A signaling in mice
Francesco Limone, Alexander Couto, Jin-Yuan Wang, Yingying Zhang, Blake T. McCourt, Cerianne Huang, Adina Minkin, Marghi Jani, Sarah K McNeer, James Keaney et al. · 2024 · Science Translational Medicine
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson’s disease
Emi Furusawa-Nishii, Bataa Solongo, Rai Kou, Soichiro Yoshikawa, A. Chiba, A. Okuzumi, Shin-ichi Ueno, Y. Hoshino, Yoko Imamichi-Tatano, Haruka Kimura et al. · 2025 · Journal of Neuroinflammation
The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis
Zihan Jiang, Honghao Huang, Yiqun Chen, Haobo Xie, Yangguang Lu, Yaoyin Ge, Ruotong Yao, Lingsheng Wang, Zihao Wu, Yiran Bu et al. · 2024 · Journal of Neuroimmunology
Peripheral-central immune crosstalk in Parkinson's disease and its association with clinical severity.
J. Greenland, Jonathan Holbrook, L. Kahanawita, M. Camacho, T. Fryer, Young T Hong, C. Williams-Gray · 2025 · Brain, behavior, and immunity
Aging and Parkinson’s disease: a complex interplay of vulnerable neurons, the immune system and the blood-brain barrier
Jonas Bendig, Anika K. Frank, Heinz Reichmann · 2024 · Ageing and Neurodegenerative Diseases
Inflammation and heterogeneity in synucleinopathies
Antoine Freuchet, Anaëlle Pinçon, Alessandro Sette, Cecilia S. Lindestam Arlehamn · 2024 · Frontiers in Immunology
Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents
Bina Patel, Julia C. Greenland, Caroline H. Williams‐Gray · 2024 · Journal of Parkinson s Disease
Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
Yun‐Beom Choi, Ambrose A. Dunn-Meynell, Michelle E. Marchese, Benjamin M. Blumberg, Deeya Gaindh, Peter C. Dowling, Wei Lü · 2021 · Alzheimer s Research & Therapy
Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson’s Disease Research and Therapeutic Development
Sarah F. McComish, Adina N. MacMahon Copas, Maeve A. Caldwell · 2022 · Frontiers in Neuroscience
DiHuangYin decoction protects dopaminergic neurons in a Parkinson's disease model by alleviating peripheral inflammation
Yuhan Wu, Hao Liu, Yule Wang, Hongda Sheng, Zhilin Chen, Dejin Xun, Huimin Wu, Shun Xiao, Yong Bi, Yi Wang · 2022 · Phytomedicine
Human microglia phenotypes in the brain associated with HIV infection
Johannes C. M. Schlachetzki, Yi Zhou, Christopher K. Glass · 2022 · Current Opinion in Neurobiology
Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy
Xiaolin Yang, Xiaoqing Zhang, Kai‐Feng Shen, Zhongke Wang, Guolong Liu, Kaixuan Huang, Zeng He, Yang Li, Zhi Hou, Shengqing Lv et al. · 2023 · Frontiers in Pharmacology
The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson’s disease
Fengjuan Jiao, Lincong Zhou, Zhao Wu · 2024 · Neurological Sciences
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease
Emil Johansson, Antoine Freuchet, Gregory P. Williams, Tanner Michealis, April Frazier, Irene Litvan, Jennifer G. Goldman, Roy N. Alcalay, David G. Standaert, Amy W. Amara et al. · 2025 · npj Parkinson s Disease
Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
E. How Shing Koy, Pierre M. Labauge, Athan C. Baillet, Clément Prati, Hubert Marotte, Yves‐Marie Pers · 2021 · Therapeutic Advances in Musculoskeletal Disease
Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson’s disease and examination of its possible etiologies: infectious or autoimmune?
Oriol de Fàbregues, María Clara Sellés, David Ramos-Vicente, Gerard Roch, Miquel Vila, Jordi Bové · 2023 · Neurobiology of Disease
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease
Jasna Šaponjić, Rebeca Mejı́as, Neda Nikolovski, Milorad Dragić, Asuman Canak, Stamatia Papoutsopoulou, Yasemin Özdemir, Kari Espolin Fladmark, Panagiotis Ntavaroukas, Nuray Bayar Muluk et al. · 2024 · International Journal of Molecular Sciences
The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer’s Disease, and mild cognitive impairment
Yueyi Yu, Huixin Shen, Qi Qin, Jing Wang, Yuting Nie, Lulu Wen, Yi Tang, Miao Qu · 2025 · Neuroscience
Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils
Amandine Roux, Xinhe Wang, Katelyn Becker, Jiyan Ma · 2020 · Journal of Parkinson s Disease
Gut–Spinal Cord Axis in Spinal Cord Injury: Bidirectional Inflammatory Mechanisms and Microbiota-Targeted Therapeutic Strategies
Jinwang Dong, Tao Xie, Cunhu Shi, Gaoqi Feng, Hengheng Zhang, Zhengwei Xu, Liang Dong · 2025 · Journal of Inflammation Research
Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
Caroline Diener, Martin Hart, Tim Kehl, Anouck Becker, Tanja Tänzer, David Schub, Lena Krammes, Martina Sester, Andreas Keller, Marcus Michael Unger et al. · 2023 · Cell Death Discovery
Impact of vitamin D3 supplementation on motor functionality and the immune response in Parkinson’s disease patients with vitamin D deficiency
Danfeng Li, Xibo Ma, Wentao Zhang, Ping Zhong, Xiaowei Zhu, Yan Chen, Shihua Liu · 2025 · Scientific Reports
New Perspectives on Immune Involvement in Parkinson’s Disease Pathogenesis
David Gate · 2022 · Journal of Parkinson s Disease
Cerebral Organoids Derived from a Parkinson’s Patient Exhibit Unique Pathogenesis from Chikungunya Virus Infection When Compared to a Non-Parkinson’s Patient
Emily M. Schultz, TyAnthony J. Jones, Sibei Xu, Dana D. Dean, Bernd Zechmann, Kelli L. Barr · 2021 · Pathogens
Celastrol Downmodulates Alpha-Synuclein-Specific T Cell Responses by Mediating Antigen Trafficking in Dendritic Cells
Lam Ng, Xiaohui Wang, Chuanbin Yang, Cheng-Fu Su, Min Li, Allen Ka Loon Cheung · 2022 · Frontiers in Immunology
Association between inflammatory markers (SII and SIRI) and anxiety levels in Parkinson’s disease
Wen Zhou, Tian-fang Zeng, Duan Liu, Ruijuan Pang, Liang Gong · 2025 · Frontiers in Psychiatry
Interleukin-17: A Putative Novel Pharmacological Target for Pathological Pain
Shao‐Jie Gao, Lin Liu, Danyang Li, Dai-Qiang Liu, Long-Qing Zhang, Jiayi Wu, Fan‐He Song, Ya‐Qun Zhou, Wei Mei · 2023 · Current Neuropharmacology
Identification of key mitochondria-related genes and their relevance to the immune system linking Parkinson's disease and primary Sjögren's syndrome through integrated bioinformatics analyses
Yuan Zong, Yi Yang, Jiawen Zhao, Lei Li, Danyang Luo, Jiawei Hu, Yiming Gao, Xianfei Xie, Linhui Shen, Sheng Chen et al. · 2024 · Computers in Biology and Medicine
The impact of anti-inflammatory therapy on Parkinson's disease incidence: A retrospective cohort study
Michele H. Potashman, Jennifer Scarlet Haas, Ambrish A. Pandit, Dana Stafkey-Mailey, Vlad Coric, Wolfgang Singer, Gil J L’Italien · 2024 · Parkinsonism & Related Disorders
Deciphering brain organoid heterogeneity by identifying key quality determinants
Tom Boerstler, Daniel V. Kachkin, Elizaveta M. Gerasimova, Naime Zagha, Federica Furlanetto, Negar Nayebzade, Luke Zappia, Michelle Boisvert, Michaela Farrell, Sonja Ploetz et al. · 2025 · Communications Biology